Yuki Shimada

1.1k total citations
66 papers, 714 citations indexed

About

Yuki Shimada is a scholar working on Oncology, Sociology and Political Science and Pharmacology. According to data from OpenAlex, Yuki Shimada has authored 66 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Sociology and Political Science and 12 papers in Pharmacology. Recurrent topics in Yuki Shimada's work include Pharmaceutical industry and healthcare (12 papers), Risk Perception and Management (11 papers) and Disaster Response and Management (10 papers). Yuki Shimada is often cited by papers focused on Pharmaceutical industry and healthcare (12 papers), Risk Perception and Management (11 papers) and Disaster Response and Management (10 papers). Yuki Shimada collaborates with scholars based in Japan, United Kingdom and United States. Yuki Shimada's co-authors include Akihiko Ozaki, Tetsuya Tanimoto, Toyoaki Sawano, Hiroaki Saito, Masaharu Tsubokura, Kana Yamamoto, Claire Leppold, Tomohiro Morita, Shuhei Nomura and Tomoyoshi Oikawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Bone and Joint Surgery.

In The Last Decade

Yuki Shimada

58 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuki Shimada Japan	15	184	159	126	107	98	66	714
Justyna Bartoszko Canada	11	6 0.0×	106 0.7×	83 0.7×	33 0.3×	23 0.2×	39	856
George K. Tokuhata United States	12	9 0.0×	14 0.1×	165 1.3×	28 0.3×	59 0.6×	26	641
G.L. Voelz United States	13	3 0.0×	31 0.2×	57 0.5×	174 1.6×	41 0.4×	27	1.1k
Renee L. Gennarelli United States	12	113 0.6×	128 0.8×	496 3.9×	1 0.0×	15 0.2×	34	953
Yichen Zhang China	15	8 0.0×	147 0.9×	201 1.6×	26 0.2×	4 0.0×	51	668
George Laking New Zealand	14	8 0.0×	73 0.5×	161 1.3×	3 0.0×	20 0.2×	41	880
Uwe Kaletsch Germany	17	4 0.0×	10 0.1×	209 1.7×	22 0.2×	51 0.5×	21	1.2k
Kumiko Saika Japan	13	12 0.1×	27 0.2×	325 2.6×	4 0.0×	16 0.2×	80	889
Wan‐Ling Hsu Japan	14	3 0.0×	34 0.2×	96 0.8×	23 0.2×	66 0.7×	20	917
William B. Feldman United States	14	37 0.2×	237 1.5×	71 0.6×	1 0.0×	12 0.1×	79	623

Countries citing papers authored by Yuki Shimada

Since Specialization

Citations

This map shows the geographic impact of Yuki Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Shimada more than expected).

Fields of papers citing papers by Yuki Shimada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Shimada. The network helps show where Yuki Shimada may publish in the future.

Co-authorship network of co-authors of Yuki Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Shimada. A scholar is included among the top collaborators of Yuki Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Shimada. Yuki Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohuchida, Kenoki, Yutaka Yamada, Yuki Shimada, et al.. (2025). Claudin18.2-positive gastric cancer-specific changes in neoadjuvant chemotherapy-driven immunosuppressive tumor microenvironment. British Journal of Cancer. 132(9). 793–804.

Sumikura, Hiroyuki, Takuma Sato, Mai Ito, et al.. (2024). A good therapeutic response to evocalcet for dropped head due to primary hyperparathyroidism: A case report. Neurology and Clinical Neuroscience. 12(6). 390–393.

Sumikura, Hiroyuki, et al.. (2024). A case of SBMA presenting with myasthenic syndrome limited to a dropped head. Neurology and Clinical Neuroscience. 12(6). 376–378.

Zhang, Bo, Kenoki Ohuchida, Yuki Shimada, et al.. (2024). Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. Journal of Experimental & Clinical Cancer Research. 43(1). 271–271. 10 indexed citations

Koga, Yutaka, Yuki Shimada, Yutaka Yamada, et al.. (2023). Clinicopathologic Features and Genetic Alterations in Mixed-Type Ampullary Carcinoma. Modern Pathology. 36(8). 100181–100181. 2 indexed citations

Nagatake, Takahiro, et al.. (2023). Lentinula Edodes Mycelia extract regulates the function of antigen-presenting cells to activate immune cells and prevent tumor-induced deterioration of immune function. BMC Complementary Medicine and Therapies. 23(1). 281–281. 5 indexed citations

Saito, Hiroaki, Akihiko Ozaki, Toyoaki Sawano, et al.. (2020). Pharmaceutical Company Payments to the Professors of Orthopaedic Surgery Departments in Japan. Journal of Bone and Joint Surgery. 102(9). e39–e39. 6 indexed citations

Saito, Hiroaki, Tetsuya Tanimoto, Masahiro Kami, et al.. (2020). New physician specialty training system impact on distribution of trainees in Japan. Public Health. 182. 143–150. 7 indexed citations

Murayama, Anju, et al.. (2020). Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatment. Liver International. 41(3). 464–469. 13 indexed citations

10.

Ozaki, Akihiko, Hiroaki Saito, Toyoaki Sawano, et al.. (2020). Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016. Health Policy. 124(7). 727–735. 33 indexed citations

11.

Ozaki, Akihiko, et al.. (2019). Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis. BMJ Open. 9(9). e028805–e028805. 31 indexed citations

12.

Sawano, Toyoaki, Yoshitaka Nishikawa, Akihiko Ozaki, et al.. (2019). Premature death associated with long-term evacuation among a vulnerable population after the Fukushima nuclear disaster. Medicine. 98(27). e16162–e16162. 14 indexed citations

13.

Kaneko, Gou, Suguru Shirotake, Yuki Shimada, et al.. (2019). Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer. SHILAP Revista de lepidopterología. 3(1). 17–20. 19 indexed citations

14.

Shimada, Yuki, Shuhei Nomura, Akihiko Ozaki, et al.. (2018). Balancing the risk of the evacuation and sheltering-in-place options: a survival study following Japan’s 2011 Fukushima nuclear incident. BMJ Open. 8(7). e021482–e021482. 14 indexed citations

15.

Leppold, Claire, Masaharu Tsubokura, Akihiko Ozaki, et al.. (2016). Sociodemographic patterning of long-term diabetes mellitus control following Japan's 3.11 triple disaster: a retrospective cohort study. BMJ Open. 6(7). e011455–e011455. 11 indexed citations

16.

Morita, Tomohiro, Masaharu Tsubokura, Shuhei Nomura, et al.. (2016). Impacts of the 2011 Fukushima nuclear accident on emergency medical service times in Soma District, Japan: a retrospective observational study. BMJ Open. 6(9). e013205–e013205. 16 indexed citations

17.

Sawano, Toyoaki, Masaharu Tsubokura, Akihiko Ozaki, et al.. (2016). Non-communicable diseases in decontamination workers in areas affected by the Fukushima nuclear disaster: a retrospective observational study. BMJ Open. 6(12). e013885–e013885. 15 indexed citations

18.

Leppold, Claire, Akihiko Ozaki, Yuki Shimada, Tomohiro Morita, & Tetsuya Tanimoto. (2016). Defining and Acting on Global Health: The Case of Japan and the Refugee Crisis. International Journal of Health Policy and Management. 5(8). 457–460. 8 indexed citations

19.

Nomura, Shuhei, Masaharu Tsubokura, R. Hayano, et al.. (2015). Compliance with the proper use of an individual radiation dosimeter among children and the effects of improper use on the measured dose: a retrospective study 18–20 months following Japan's 2011 Fukushima nuclear incident. BMJ Open. 5(12). e009555–e009555. 10 indexed citations

20.

Asanuma, Yu, Yuki Shimada, Kazuhiro Yokota, et al.. (2012). Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. Modern Rheumatology. 23(2). 269–275. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact